Government moves to secure 600 acres in Wakiso for Dei BioPharma expansion
The Ugandan government is acquiring 600 acres of land in Wakiso to support the expansion of Dei BioPharma's manufacturing facility. The project aims to increase local production of vaccines and specialized medicines to reduce reliance on imports and meet international export standards.
Why it matters
Expanding local pharmaceutical manufacturing in Africa is critical for improving healthcare accessibility and reducing dependence on foreign medical supplies.
L-R: Attorney General Sam Mayanja, Privitization and Investment State Minister Amina Mukalazi, and Lands Minister Judith Nabakooba during a meeting at Dei Bio Pharma Ltd in Gombe Division. PHOTO/NOELINE NABUKENYA
The government of Uganda has initiated steps to acquire an additional 600 acres of land in Gombe Division, Nansana Municipality, Wakiso District, to facilitate the expansion of Dei BioPharma Limited’s pharmaceutical and vaccine manufacturing facility.
The proposed expansion, targeting Wabitembe, Kiryowa, and Kigoogwa villages, aims to scale up the local production of advanced medicines, vaccines, and specialized therapies for both domestic consumption and international export markets. Speaking during a community meeting with local residents and senior government officials, Dr Matthias Magoola, the founder of Dei BioPharma Limited, explained that the additional land is crucial for building new production lines and meeting stringent international manufacturing standards required to export pharmaceuticals to regions such as the United States.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in